BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31995957)

  • 1. Macrophage activation syndrome as a complication of rheumatologic disorders, a report from Iran.
    Assari R; Sadeghi P; Mirmohammadsadeghi A; Ebadi F; Ziaee V
    Reumatismo; 2020 Jan; 71(4):189-198. PubMed ID: 31995957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single center clinical analysis of macrophage activation syndrome complicating juvenile rheumatic diseases.
    Huang S; Liu Y; Yan W; Zhang T; Wang P; Zhu M; Zhang X; Zhou P; Fan Z; Yu H
    Pediatr Rheumatol Online J; 2024 May; 22(1):58. PubMed ID: 38783316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities.
    Naveen R; Jain A; Muhammed H; Gupta L; Misra DP; Lawrence A; Agarwal V; Misra R; Aggarwal A
    Rheumatol Int; 2021 Mar; 41(3):625-631. PubMed ID: 33388903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
    Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
    Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease].
    Yao HH; Yang F; Tang SM; Zhang X; He J; Jia Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):966-974. PubMed ID: 38101776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China.
    Zou LX; Zhu Y; Sun L; Ma HH; Yang SR; Zeng HS; Xiao JH; Yu HG; Guo L; Xu YP; Lu MP
    World J Pediatr; 2020 Feb; 16(1):89-98. PubMed ID: 31612427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Minoia F; Bovis F; Davì S; Horne A; Fischbach M; Frosch M; Huber A; Jelusic M; Sawhney S; McCurdy DK; Silva CA; Rigante D; Unsal E; Ruperto N; Martini A; Cron RQ; Ravelli A;
    Ann Rheum Dis; 2019 Oct; 78(10):1357-1362. PubMed ID: 31296501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The frequency of macrophage activation syndrome and disease course in systemic juvenile idiopathic arthritis.
    Çakan M; Karadağ ŞG; Tanatar A; Ayaz NA
    Mod Rheumatol; 2020 Sep; 30(5):900-904. PubMed ID: 31462146
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.
    Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Likhacheva TS; Isupova EA; Glebova NI; Kuchinskaya EM; Balbotkina EV; Buchinskaya NV; Kalashnikova OV; Chasnyk VG
    Semin Arthritis Rheum; 2015 Feb; 44(4):417-22. PubMed ID: 25300700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study.
    Otar Yener G; Paç Kısaarslan A; Ulu K; Atalay E; Haşlak F; Özdel S; Bozkaya Yücel B; Gezgin Yıldırım D; Çakmak F; Öztürk K; Çakan M; Balık Z; Hasbal Akkuş C; Yıldız M; Erat T; Çetin BŞ; Yılmaz M; Bağlan E; Laçinel Gürlevik S; Atasayan V; Karadağ ŞG; Adrovic A; Çağlayan Ş; Tanatar A; Demirkan FG; Coşkuner T; Akgün Ö; Kasap Cüceoğlu M; Kavrul Kayaalp G; Şahin S; Başaran Ö; Demir F; Barut K; Çiftel M; Gürses D; Baykan A; Özsürekçi Y; Karagöz T; Sönmez HE; Bilginer Y; Aktay Ayaz N; Aydoğ Ö; Yüksel S; Sözeri B; Kasapçopur Ö; Özen S
    Rheumatol Int; 2022 May; 42(5):879-889. PubMed ID: 34491393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Lee PY; Schulert GS; Canna SW; Huang Y; Sundel J; Li Y; Hoyt KJ; Blaustein RB; Wactor A; Do T; Halyabar O; Chang MH; Dedeoglu F; Case SM; Meidan E; Lo MS; Sundel RP; Richardson ET; Newburger JW; Hershfield MS; Son MB; Henderson LA; Nigrovic PA
    Ann Rheum Dis; 2020 Feb; 79(2):225-231. PubMed ID: 31707357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis.
    Reddy VV; Myles A; Cheekatla SS; Singh S; Aggarwal A
    Int J Rheum Dis; 2014 Mar; 17(3):261-7. PubMed ID: 24417800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic Changes, Cut-Off Points, Sensitivity, and Specificity of Laboratory Data to Differentiate Macrophage Activation Syndrome from Active Disease.
    Assari R; Ziaee V; Mirmohammadsadeghi A; Moradinejad MH
    Dis Markers; 2015; 2015():424381. PubMed ID: 26063955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performances of the "MS-score" And "HScore" in the diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis patients.
    Sag E; Keskin A; Atalay E; Demir S; Cuceoglu MK; Akca UK; Batu ED; Bilginer Y; Ozen S
    Rheumatol Int; 2021 Jan; 41(1):87-93. PubMed ID: 33215249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden Hypotension and Increased Serum Interferon-γ and Interleukin-10 Predict Early Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis.
    Guo L; Xu Y; Qian X; Zou L; Zheng R; Teng L; Zheng Q; Leung Jung LK; Lu M
    J Pediatr; 2021 Aug; 235():203-211.e3. PubMed ID: 33581106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of macrophage activation syndrome in children with rheumatic disorders.
    Moradinejad MH; Ziaee V
    Minerva Pediatr; 2011 Dec; 63(6):459-66. PubMed ID: 22075800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is it possible to predict a disease course prone to macrophage activation syndrome at systemic juvenile idiopathic arthritis diagnosis?
    Batu ED; Sener S; Balık Z; Bayındır Y; Cam V; Kasap Cuceoglu M; Uysal O; Aliyev E; Basaran Ö; Bilginer Y; Özen S
    Clin Rheumatol; 2024 Jan; 43(1):415-421. PubMed ID: 38012469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of baseline laboratory findings of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis and multisystem inflammatory syndrome in children.
    Aydın F; Çelikel E; Ekici Tekin Z; Coşkun S; Sezer M; Karagöl C; Kaplan MM; Tekgöz N; Kurt T; Özcan S; Kavurt AV; Özkaya Parlakay A; Çelikel Acar B
    Int J Rheum Dis; 2021 Apr; 24(4):542-547. PubMed ID: 33550678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis.
    Bennett TD; Fluchel M; Hersh AO; Hayward KN; Hersh AL; Brogan TV; Srivastava R; Stone BL; Korgenski EK; Mundorff MB; Casper TC; Bratton SL
    Arthritis Rheum; 2012 Dec; 64(12):4135-42. PubMed ID: 22886474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and correct diagnosis of macrophage activation syndrome.
    Cron RQ; Davi S; Minoia F; Ravelli A
    Expert Rev Clin Immunol; 2015; 11(9):1043-53. PubMed ID: 26082353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.